BIDU vs HALO · rev $18.46B vs P/E 15, rev $857.7M
Baidu Inc (BIDU) versus Halozyme Therapeutics Inc (HALO) — a side-by-side from cached financials, not a winner call.
Baidu Inc (BIDU) is a internet content & information company listed on US.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
Latest reported BIDU revenue for 2025-12-31 was $18.46B. Net income was $799.0M. Revenue was up 1.2% from 2024-12-31 to 2025-12-31. BIDU currently screens at market cap $37.98B.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
BIDU currently screens at market cap $37.98B. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Not investment advice. Open the BIDU and HALO stock pages for the full models.
Not investment advice.